The Centers for Medicare and Medicaid Services is proposing to formalize its policy against private insurance plans designating some covered drugs as “non-essential health benefits,” which could limit the use of copay maximizer programs.
Key Takeaways
-
CMS 'codifies' policy barring individual and small group plans from designating covered drugs as 'non-EHB' and not subject to annual limits on cost sharing.
The proposal is part of the CMS Notice of Benefit and Payment Parameters for 2025 proposed rule released on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?